pre-IPO PHARMA

COMPANY OVERVIEW

Outpost Medicine is a biopharmaceutical company focused on the development of novel therapeutics for the treatment of urologic and gastrointestinal disorders. ​Located in Indianapolis and London, Outpost is a private company launched in 2016.


LOCATION

  • Indianapolis, IN, USA
  • London, , UK

  • THERAPEUTIC AREAS

  • Gastrointestinal Disease

  • WEBSITE

    https://www.outpostmedicine.com


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    adams-street-partners frazier-healthcare novo-holdings takeda-ventures vivo-capital


    PRESS RELEASES


    May 1, 2018

    Arena Pharmaceuticals and Outpost Medicine Enter into Licensing Agreement for Undisclosed Novel Compound


    Dec 4, 2017

    Outpost Medicine Announces Appointment of Dr. Ian Mills as Chief Medical Officer


    Nov 15, 2017

    Outpost Medicine Appoints Scott Byrd as Chief Executive Officer and Raises $20 Million in Series A Financing Extension


    Jul 18, 2016

    Outpost Medicine Expands Senior Leadership Team


    Mar 14, 2016

    Takeda and Frazier Healthcare Partners Launch Outpost Medicine to Develop New Therapeutics in Urology and Gynecology


    For More Press Releases


    Google Analytics Alternative